SPECTRUM PHARMACEUTICALS INC acquired Spectrum Pharmaceuticals, Inc.

SPECTRUM PHARMACEUTICALS INC -> Spectrum Pharmaceuticals, Inc. · $1.14

"The addition of Spectrum's commercial capabilities and ROLVEDON, a novel long-acting G-CSF product recently launched into a blockbuster market in October 2022, exemplifies Assertio's attractiveness as an acquirer of new, accretive assets across diverse therap